Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model.

Nizzardo M, Simone C, Rizzo F, Salani S, Dametti S, Rinchetti P, Del Bo R, Foust K, Kaspar BK, Bresolin N, Comi GP, Corti S.

Sci Adv. 2015 Mar 13;1(2):e1500078. doi: 10.1126/sciadv.1500078. eCollection 2015 Mar.

2.

Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches.

Nizzardo M, Simone C, Dametti S, Salani S, Ulzi G, Pagliarani S, Rizzo F, Frattini E, Pagani F, Bresolin N, Comi G, Corti S.

Sci Rep. 2015 Jun 30;5:11746. doi: 10.1038/srep11746.

3.

Experimental Advances Towards Neural Regeneration from Induced Stem Cells to Direct In Vivo Reprogramming.

Dametti S, Faravelli I, Ruggieri M, Ramirez A, Nizzardo M, Corti S.

Mol Neurobiol. 2016 May;53(4):2124-31. doi: 10.1007/s12035-015-9181-7. Epub 2015 May 2. Review.

PMID:
25934102
4.

Therapeutic development in amyotrophic lateral sclerosis.

Bucchia M, Ramirez A, Parente V, Simone C, Nizzardo M, Magri F, Dametti S, Corti S.

Clin Ther. 2015 Mar 1;37(3):668-80. doi: 10.1016/j.clinthera.2014.12.020. Epub 2015 Feb 7. Review.

PMID:
25666449

Supplemental Content

Loading ...
Support Center